MS patients may soon pee away painful bladder tests

NCT ID NCT06161376

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether a substance in urine, called S1P, can help doctors check bladder function in people with multiple sclerosis (MS). Many MS patients have overactive bladder, but the standard test is invasive and uncomfortable. Researchers will measure S1P levels in 400 MS patients before and after treatment to see if it matches results from the standard test. If it works, it could lead to a simple, pain-free way to monitor bladder health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple urine test to monitor bladder problems in MS, avoiding uncomfortable invasive procedures.
What could go wrong
This is an early-stage biomarker study, not a treatment trial. The urine test may not prove reliable enough to replace current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Toulouse Hospital

    RECRUITING

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.